Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Ganmai Dazao Decoction is a Traditional Chinese Medicine (TCM) herbal formula derived from the classic Ganmai Dazao Decoction, which traditionally consists of *Glycyrrhizae Radix* (Gan Cao), *Tritici Fructus Levis* (Xiao Mai), and *Jujubae Fructus* (Da Zao). This modified version is specifically being investigated by the Yueyang Integrated Traditional Chinese and Western Medicine Hospital for the treatment of tumor-associated sleep disorders (insomnia) in cancer patients. The formula is hypothesized to improve sleep quality and regulate neuroendocrine function, potentially by modulating neurotransmitters such as GABA or serotonin, although the exact molecular targets of the multi-herb mixture are complex. In clinical trials, it is often used as an adjuvant therapy alongside standard sedative-hypnotic medications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Ganmai Dazao Decoction.